Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis

Gunter Schuch, Oliver Kisker, Anthony Atala, Shay Soker

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

There is increasing evidence for the implication of tumor-derived angiogenic and anti-angiogenic factors in controlling tumor growth in vivo. In this study, we documented the production of inhibitors of angiogenesis by pancreatic cancer cells and examined how changes in the balance between pro- and anti-angiogenic factors regulate tumor growth in vivo. The human pancreatic cancer cell line Hs-776T (HS-W) produces slow-growing tumors in SCID mice. Cells of a variant form (HS-R) of Hs-776T produced faster-growing tumors compared to HS-W. Characterization of HS-W and HS-R cells in vitro showed similar proliferation rates and production of the angiogenic factors vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Analyzes of anti-angiogenic factors showed comparable levels of angiostatin and thrombospondin 1 and 2, but endostatin was only detected in conditioned media of HS-W cells and was absent in HS-R. Cell proliferation was similar in both tumor types in vivo, whereas HS-W tumors demonstrated increased apoptosis with a high percentage of apoptotic endothelial cells (EC). Subsequently, VEGF was over-expressed in Hs-776T cells (HS-VF), resulting in rapidly growing tumors and lowering tumor and EC apoptosis. Collectively, our study confirms that tumor growth is dependent on its ability to increase the angiogenic stimulus or to reduce the amounts of endogenous anti-angiogenic factors.

Original languageEnglish
Pages (from-to)181-190
Number of pages10
JournalAngiogenesis
Volume5
Issue number3
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Angiogenesis Modulating Agents
Modulators
Tumors
Angiogenesis Inducing Agents
Growth
Neoplasms
Endothelial cells
Pancreatic Neoplasms
Cell death
Vascular Endothelial Growth Factor A
Endothelial Cells
Angiostatins
Endostatins
Apoptosis
Thrombospondin 1
Cells
Angiogenesis Inhibitors
SCID Mice
Fibroblast Growth Factor 2
Conditioned Culture Medium

Keywords

  • Angiostatin
  • Apoptosis
  • BFGF
  • Endostatin
  • Proliferation
  • Thrombospondin
  • VEGF

ASJC Scopus subject areas

  • Cancer Research
  • Pathology and Forensic Medicine
  • Clinical Biochemistry
  • Polymers and Plastics

Cite this

Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis. / Schuch, Gunter; Kisker, Oliver; Atala, Anthony; Soker, Shay.

In: Angiogenesis, Vol. 5, No. 3, 01.12.2002, p. 181-190.

Research output: Contribution to journalArticle

Schuch, Gunter ; Kisker, Oliver ; Atala, Anthony ; Soker, Shay. / Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis. In: Angiogenesis. 2002 ; Vol. 5, No. 3. pp. 181-190.
@article{2a7eed70cc8541ffb40f0dcda307291e,
title = "Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis",
abstract = "There is increasing evidence for the implication of tumor-derived angiogenic and anti-angiogenic factors in controlling tumor growth in vivo. In this study, we documented the production of inhibitors of angiogenesis by pancreatic cancer cells and examined how changes in the balance between pro- and anti-angiogenic factors regulate tumor growth in vivo. The human pancreatic cancer cell line Hs-776T (HS-W) produces slow-growing tumors in SCID mice. Cells of a variant form (HS-R) of Hs-776T produced faster-growing tumors compared to HS-W. Characterization of HS-W and HS-R cells in vitro showed similar proliferation rates and production of the angiogenic factors vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Analyzes of anti-angiogenic factors showed comparable levels of angiostatin and thrombospondin 1 and 2, but endostatin was only detected in conditioned media of HS-W cells and was absent in HS-R. Cell proliferation was similar in both tumor types in vivo, whereas HS-W tumors demonstrated increased apoptosis with a high percentage of apoptotic endothelial cells (EC). Subsequently, VEGF was over-expressed in Hs-776T cells (HS-VF), resulting in rapidly growing tumors and lowering tumor and EC apoptosis. Collectively, our study confirms that tumor growth is dependent on its ability to increase the angiogenic stimulus or to reduce the amounts of endogenous anti-angiogenic factors.",
keywords = "Angiostatin, Apoptosis, BFGF, Endostatin, Proliferation, Thrombospondin, VEGF",
author = "Gunter Schuch and Oliver Kisker and Anthony Atala and Shay Soker",
year = "2002",
month = "12",
day = "1",
doi = "10.1023/A:1023893931057",
language = "English",
volume = "5",
pages = "181--190",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis

AU - Schuch, Gunter

AU - Kisker, Oliver

AU - Atala, Anthony

AU - Soker, Shay

PY - 2002/12/1

Y1 - 2002/12/1

N2 - There is increasing evidence for the implication of tumor-derived angiogenic and anti-angiogenic factors in controlling tumor growth in vivo. In this study, we documented the production of inhibitors of angiogenesis by pancreatic cancer cells and examined how changes in the balance between pro- and anti-angiogenic factors regulate tumor growth in vivo. The human pancreatic cancer cell line Hs-776T (HS-W) produces slow-growing tumors in SCID mice. Cells of a variant form (HS-R) of Hs-776T produced faster-growing tumors compared to HS-W. Characterization of HS-W and HS-R cells in vitro showed similar proliferation rates and production of the angiogenic factors vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Analyzes of anti-angiogenic factors showed comparable levels of angiostatin and thrombospondin 1 and 2, but endostatin was only detected in conditioned media of HS-W cells and was absent in HS-R. Cell proliferation was similar in both tumor types in vivo, whereas HS-W tumors demonstrated increased apoptosis with a high percentage of apoptotic endothelial cells (EC). Subsequently, VEGF was over-expressed in Hs-776T cells (HS-VF), resulting in rapidly growing tumors and lowering tumor and EC apoptosis. Collectively, our study confirms that tumor growth is dependent on its ability to increase the angiogenic stimulus or to reduce the amounts of endogenous anti-angiogenic factors.

AB - There is increasing evidence for the implication of tumor-derived angiogenic and anti-angiogenic factors in controlling tumor growth in vivo. In this study, we documented the production of inhibitors of angiogenesis by pancreatic cancer cells and examined how changes in the balance between pro- and anti-angiogenic factors regulate tumor growth in vivo. The human pancreatic cancer cell line Hs-776T (HS-W) produces slow-growing tumors in SCID mice. Cells of a variant form (HS-R) of Hs-776T produced faster-growing tumors compared to HS-W. Characterization of HS-W and HS-R cells in vitro showed similar proliferation rates and production of the angiogenic factors vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Analyzes of anti-angiogenic factors showed comparable levels of angiostatin and thrombospondin 1 and 2, but endostatin was only detected in conditioned media of HS-W cells and was absent in HS-R. Cell proliferation was similar in both tumor types in vivo, whereas HS-W tumors demonstrated increased apoptosis with a high percentage of apoptotic endothelial cells (EC). Subsequently, VEGF was over-expressed in Hs-776T cells (HS-VF), resulting in rapidly growing tumors and lowering tumor and EC apoptosis. Collectively, our study confirms that tumor growth is dependent on its ability to increase the angiogenic stimulus or to reduce the amounts of endogenous anti-angiogenic factors.

KW - Angiostatin

KW - Apoptosis

KW - BFGF

KW - Endostatin

KW - Proliferation

KW - Thrombospondin

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=0037502771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037502771&partnerID=8YFLogxK

U2 - 10.1023/A:1023893931057

DO - 10.1023/A:1023893931057

M3 - Article

C2 - 12831059

AN - SCOPUS:0037502771

VL - 5

SP - 181

EP - 190

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 3

ER -